FindTrial
Sign In

A study to evaluate the efficacy of Phalatrikadi Kashaya and Daruharidraghana Vati in Non- Alcoholic Fatty Liver Disease

A clinical study to determine the efficacy of Phalatrikadi Kashaya and Daruharidraghana Vati in the management of Non- Alcoholic Fatty Liver Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033410
Enrollment
50
Registered
2021-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Phalatrikadi Kashaya Daruharidaghana Vati : Phalatrikadi Kashaya- 48 ml twice a day for 12 weeks Daruharidaghana Vati - 500mg twice a day for 12 weeks Control Intervention1: Life sty

Sponsors

RGGPG Ayurvedic College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Altered serum liver enzymes- AST and/or ALT >normal (35-40 U/L) -

Exclusion criteria

Exclusion criteria: Patients consuming alcohol Patients having Hepatitis B/ Hepatitis C, malignancy of liver USG evidence of cirrhosis or necrosis of liver

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of Phaltrikadi Kashaya and Daruharidraghana Vati in management of Non Alcoholic Fatty Liver DiseaseTimepoint: 12 weeks—

Secondary

MeasureTime frame
To assess the clinical safety of Phaltrikadi Kashaya and Daruharidraghana Vati in management of Non Alcoholic Fatty Liver DiseaseTimepoint: 12 weeks—

Countries

India

Contacts

Public ContactDr Deepika Bhardwaj

R.G.G.P.G Ayurvedic College Paprola

drvijaychaudhary@gmail.com9418130228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026